December 18, 2014 12:38 PM ET


Company Overview of Advanced Accelerator Applications S.A.

Company Overview

Advanced Accelerator Applications S.A., a radiopharmaceutical company, develops, produces, and commercializes molecular nuclear medicine (MNM) diagnostic and therapeutic products in France, Italy, Spain, Israel, Canada, the United States, and internationally. It provides positron emission tomography (PET) products, including Gluscan, a branded 18-fluorodeoxyglucose PET imaging agent that assists in the diagnosis of serious medical conditions primarily in oncology through assessing glucose metabolism; IASOflu, which images bone metastases; IASOdopa to diagnose Parkinson’s disease and tumors in various indications; and IASOcholine for diagnosing prostate cancer. The company also offers single-...

20 Rue Diesel

Saint Genis Pouilly,  01630


Founded in 2002

314 Employees


33 4 50 99 30 70


33 4 50 99 30 71

Key Executives for Advanced Accelerator Applications S.A.

Age: 48
Group CFO
Age: 51
Chief Operating Officer
Age: 56
Group Head of R&D
Age: 56
Head of Clinical Development
Age: 59
Compensation as of Fiscal Year 2014.

Advanced Accelerator Applications S.A. Key Developments

Advanced Accelerator Applications S.A. Announces Earnings Results for the First Nine Months of 2014

Advanced Accelerator Applications S.A. announced earnings results for the first nine months of 2014. For the nine months, sales of EUR 50,156,000 compared to EUR 38,919,000 a year ago. Operating income was EUR 2,199,000 compared to EUR 1,373,000 a year ago. Net income from continuing operations was EUR 1,135,000 compared to loss of EUR 2,038,000 a year ago. Adjusted EBITDA was EUR 9,668,000 compared to EUR 7,643.000 a year ago. Net operating cash-flow was EUR 9 million, an increase of 33% compared to the 6.7 million a year ago.

Advanced Accelerator Mulls Acquisitions

Advanced Accelerator Applications SA is looking for acquisitions. Advanced Accelerator Applications SA has filed an initial public offering in the amount of $100 million and intends to use the net proceeds for general corporate purposes, including acquisitions of, or investment in, businesses or assets.

Advanced Accelerator Applications SA Announces Earnings Results for the Full Year Ended December 31, 2013

Advanced Accelerator Applications SA announced earnings results for the full year ended December 31, 2013. For the period, the company reported net loss for the year from continuing operations of EUR 9,861,000 compared with EUR 16,912,000 for the same period a year ago. EBITDA was EUR 10,638,000 compared with EUR 6,577,000 for the same period a year ago. Sales for the year increased by 31.77% to EUR 53.8 million compared with EUR 40.8 million for the same period a year ago.

Similar Private Companies By Industry

Company Name Region
Polyplus-transfection SA Europe
CARLINA Technologies S.A.S. Europe
Glycode SAS Europe
High-tech Bio Activities SA Europe
Nautilus Biotech S.A. Europe

Recent Private Companies Transactions

March 4, 2014
Imaging Equipment Ltd
Private Placement
February 17, 2014

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Advanced Accelerator Applications S.A., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at